I did not think much of INSM short position until I saw the Options handed out to the hedge fund President.he will not buy those shares until the price is half of what it is today.This crowd is nothing but a bunch of scam artists
someone who was one of the losers years ago.IPLEX is not in Insmeds presentation.That says it all.Ignore the hype and listen to the company
No press release for anything in the good ole US
if there was Insmed would have issued one.this is a material event
Any real news on iplex ? I didn't think so.
More significant in my book is the very structure of Forest Labs. In many respects,Forest Labs is a great salesforce attached to a bank account and savvy deal-makers. Forest Labs has virtually no internal R&D efforts, so buying Forest Labs would, at least to me, seem like more of an effort to buy time for Soriot to restructure/refill the pipeline and internal R&D efforts as opposed to a Genentech-type deal that brings fundamental new capabilities to AstraZeneca.
then they let the chief financial officier go followed by the President and buy shares after institutions dump and then hire hedge fund deal broker.HELLLLL OOOOO!
Arikace is years out and no Phase two trial results will match Phase3. and to think Insmed could compete with Forrest labs adds to YOUR FUD!